Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 4
Author(s): A. Blokland
Affiliation:
Export Options
About this article
Cite this article as:
Blokland A. , Meet Our Editorial Board Member, Current Neuropharmacology 2018; 16 (4) . https://dx.doi.org/10.2174/1570159X1604180501124304
DOI https://dx.doi.org/10.2174/1570159X1604180501124304 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
17
2
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Opioids: Other Routes for Use in Recovery Room
Current Drug Targets Antioxidants as Potentially Safe Antidotes for Organophosphorus Poisoning
Current Enzyme Inhibition Gender, Hormones and the Transmissible Encephalopathies
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Endocannabinoid System: A New Molecular Target for the Treatment of Tobacco Addiction
CNS & Neurological Disorders - Drug Targets The Translocator Protein 18 kDa (TSPO) and Its Role in Mitochondrial Biology and Psychiatric Disorders
Mini-Reviews in Medicinal Chemistry Pollutants in Organic Chemistry and Medicinal Chemistry Education Laboratory. Experimental and Machine Learning Studies
Current Topics in Medicinal Chemistry Novel Medication Targets for the Treatment of Alcoholism: Preclinical Studies
Recent Patents on CNS Drug Discovery (Discontinued) Development of Crystalline Cellulosic Fibres for Sustained Release of Drug
Current Topics in Medicinal Chemistry Vitamin D Analogs: Mechanism of Action and Therapeutic Applications
Current Medicinal Chemistry Biology of Cox-2: An Application in Cancer Therapeutics
Current Drug Targets Meet Our Editorial Board Member
Current Neuropharmacology PUFA for Human Health: Diet or Supplementation?
Current Pharmaceutical Design Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) The Role of B Cells in Multiple Sclerosis: Implications for B-Cell-Targeted Therapy
Current Medicinal Chemistry Cannabinoid Receptors as Therapeutic Targets
Current Pharmaceutical Design Molecular Biomarkers in Schizophrenia – Implications for Clinical Practice
Current Psychiatry Reviews Stem Cell Therapy for the Treatment of Myocardial Infarction
Current Pharmaceutical Design Overview on the Tricks of HIV Tat to Hit the Blood Brain Barrier
Current HIV Research Drug Targets for Obesity and Depression: From Serotonin to Leptin
Current Drug Targets Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia
Central Nervous System Agents in Medicinal Chemistry